INTERNATIONAL PATENT: DANA-FARBER CANCER INSTITUTE, INC., THE GENERAL HOSPITAL CORPORATION, THE BROAD INSTITUTE, INC. FILES APPLICATION FOR "MINOR HISTOCOMPATIBILITY ANTIGEN MARKERS ASSOCIATED WITH GRAFT VERSUS LEUKEMIA EFFECT AND USES THEREOF"

GENEVA, Aug. 26 -- DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline AvenueBoston, Massachusetts 02215-5450), THE GENERAL HOSPITAL CORPORATION (55 Fruit StreetBoston, Massachusetts 02114), THE BROAD INSTITUTE, INC. (415 Main StreetCambridge, Massachusetts 02142) filed a patent application (PCT/US2025/014985) for "MINOR HISTOCOMPATIBILITY ANTIGEN MARKERS ASSOCIATED WITH GRAFT VERSUS LEUKEMIA EFFECT AND USES THEREOF" on Feb 07, 2025. With publication no. WO/2025/174664, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Ca...